首页|中国医药科技型创新企业支持政策量化分析

中国医药科技型创新企业支持政策量化分析

扫码查看
目的 以"支持政策量化分析"为框架,分析中国医药科技型创新企业支持政策的制定及实施情况,从而为中国医药科技型创新企业政策落实和完善提供参考.方法 采用Roy Rothwell和Walter Zegveld的创新政策工具作为分析基础,结合政策类型维度对政策进行量化分析.结果 共筛选出 47 篇有效政策文件,其中包括国家发布的 22 篇和北京市政府发布的 25 篇.通过政策条款拆解,共纳入 104 项政策工具.环境型政策工具占比最高(60.58%),需求型和供给型政策工具相对较少.从政策类型角度看,规划类政策文件较多(25 篇),而具体实施型政策相对较少(22 篇).结论 应当重点优化支持政策的制定阶段,完善供给型和需求型政策工具的使用,以更好地满足医药科技型创新企业的需求.
Quantitative analysis of the supporting policies for pharmaceutical science and technology innovative enterprises in China
Objective Based on the framework of"quantitative analysis of supporting policies",this study focuses on the formulation and implementation of supporting policies for pharmaceutical science and technology innovative enterprises in China,so as to provide a certain reference for the implementation and improvement of policies for pharmaceutical science and technology innovative enterprises in China.Methods This study used Roy Rothwell and Walter Zegveld's innovative policy tools as the basis for analysis,and combined with the dimension of policy type,the policy was quantitatively analyzed.Results A total of 47 effective policy documents were selected,including 22 issued by the state and 25 issued by Beijing municipal government.A total of 104 policy instruments were included through the dismantling of policy provisions.Specifically,environment-based policy tools accounted for the highest proportion(60.58%),while demand-based and supply-based policy tools were relatively few.From the perspective of policy types,there were more planning policy documents(25 articles),while there were relatively few specific implementation policies(22 articles).Conclusion It is necessary to focus on optimizing the formulation stage of support policies and improving the use of supply-oriented and demand-oriented policy tools to better meet the needs of pharmaceutical science and technology innovative enterprises.

Pharmaceutical science and technology innovative enterprisesInnovation and developmentPolicy toolsPolicy formulationQuantitative analysis

赵倩倩、陈柯羽、杨珑平、刘泽坤、杨俊涛、李青

展开 >

中国医学科学院/北京协和医学院卫生健康管理政策学院,北京 100730

中国医学科学院/北京协和医学院,北京 100730

医药科技型创新企业 创新发展 政策工具 政策制定 量化分析

2024

中国现代医生
中国医学科学院

中国现代医生

影响因子:1.571
ISSN:1673-9701
年,卷(期):2024.62(13)
  • 18